TMCnet News
Amtech Posts 3Q Fiscal 2014 Results [Professional Services Close - Up](Professional Services Close - Up Via Acquire Media NewsEdge) Amtech Systems reported results for its third fiscal quarter ending June 30. In its release on August 7, the company noted operational and financial highlights for 3Q 2014 -Shipped new PECVD systems to respected Korean customer -Shipped new high density, high throughput diffusion system to key customer in Taiwan -Installed new solar implant system at European solar research center -Customer orders of $17.9 million; solar $12.3 million -Shipments of $14.6 million; solar $7.3 million -Book to bill ratio of 1.2:1; solar 1.7:1 -Net revenue of $9.2 million (net of $5.4 million of deferred revenue) -Quarter-end backlog of $39.4 million (solar $30.6 million); solar backlog up 59 percent from one year ago -Net loss of $5.3 million, or $0.53 per share Financial Highlights for Nine Months Ended June 30 -Customer orders of $50.2 million; solar $29.1 million; up 43 and 37 percent respectively compared to the same period a year ago -Shipments of $51.8 million; solar $29.2 million -Book to bill ratio of 1.0:1; solar 1.0:1 -Net revenue of $36.7 million (net of $15.1 million of deferred revenue) up 32 percent from the same period a year ago -Net loss of $9.8 million compared to $18.4 million in FY 2013, or $1.01 net loss per share compared to a net loss per share of $1.93 Fokko Pentinga, CEO of Amtech, commented, "We are pleased with the progress made in the quarter on many fronts. We shipped our new PECVD system to a highly respected Korean customer, our new high density, high throughput diffusion system to a key customer in Taiwan, and the Kingstone ion implant system, which shipped in April to the Energy Research Centre of The Netherlands, has been installed. We are now positioned to start joint development efforts on next generation, higher efficiency cell technology with this highly respected partner. We have also made excellent progress on our n-type cell line with our US customer in San Antonio, Texas. Furthermore, we announced the first production order for our solar implant system from a customer in China." Pentinga continued, "Year-to-date, we have booked over $50 million in orders, including $29 million in solar orders. This represents a healthy backlog as we move into the second half of calendar 2014. Our selective investment in solar research and development programs through the down-cycle not only doubled the size of the market we can serve, but is delivering new business as reflected in the third quarter's 59 percent increase in our solar backlog compared to the third quarter of 2013. We believe we have successfully participated in pre-recovery solar business opportunities and continue to believe the real recovery will start in 2015." Brad Anderson, CFO, commented "Due to the significant amount of new products we have shipped in the last several quarters, we have high deferrals of revenue which lower the amount reported on our income statement. For the quarter ended June 30, we shipped approximately $14.6 million of products and services and had a net revenue deferral of approximately $5.4 million, resulting in net revenues of $9.2 million. We expect to see recognition of these deferrals in the coming quarters. We continue to manage our cash while prudently investing in what we believe to be a significant market opportunity, the advancement of our technologies and the future profitable growth of the Company." Financial Results According to the company, net revenue for the third quarter of fiscal 2014 was $9.2 million compared to $12.7 million in the preceding quarter and $10.4 million in the third quarter of fiscal 2013. The decrease is due primarily to the high level of revenue deferred in the latest quarter, resulting from the shipment of new products, including our PECVD and ion implant equipment. Customer orders in the third quarter of fiscal 2014 were $17.9 million ($12.3 million solar), compared to $21.5 million ($13.6 million solar) in the preceding quarter and $20.7 million ($15.1 million solar) in the third quarter of fiscal 2013. At June 30, the Company's total order backlog was $39.4 million, an increase of 27 percent compared to total backlog of $31.0 million at March 31. Total backlog at June 30, includes $30.6 million in solar orders and deferred revenue, a 49 percent increase compared to solar backlog of $20.5 million at March 31. Backlog includes deferred revenue and customer orders that are expected to ship within the next 12 months. Amtech said that gross margin in the third quarter of fiscal 2014 was 18 percent, compared to 23 percent in the previous quarter and negative margins in the third quarter of fiscal 2013. The lower margins sequentially resulted primarily from higher profit deferrals in the most recent quarter. Negative margins in the third quarter of fiscal 2013 resulted primarily from inventory write-downs. Selling, general and administrative (SG&A) expenses in the third quarter of fiscal 2014 were $4.1 million compared to $5.4 million in the third quarter of fiscal 2013. The decrease is primarily due to lower stock-based compensation expense. SG&A expenses include $0.2 million and $1.6 million of stock-based compensation expense in the third quarter of fiscal 2014 and fiscal 2013, respectively. Research and Development (R&D) expense was $1.4 million in the third quarter of fiscal 2014 compared to $1.9 million in the third quarter of fiscal 2013. The reduction in R&D expense is primarily due to the recognition of government grant funding during the third quarter of fiscal 2014. Partially offsetting the higher grant recognition was increased spending on the development of equipment for the solar industry, as well as higher activity in the development of the ion implant technology for additional markets. Depreciation and amortization in the third quarter of fiscal 2014 was $591,000, compared to $632,000 in the third quarter of fiscal 2013. Amtech reported that income tax expense in the third quarter of fiscal 2014 and 2013 was $1.3 million and $2.6 million, respectively. A provision was required, due to the effect of book/ tax differences and valuation allowances on net operating losses in certain tax jurisdictions in which the company operates. The net loss for the third quarter of fiscal 2014 was $5.3 million, or $0.53 per share, compared to a net loss for the third quarter of fiscal 2013 of $12.1 million, or $1.27 per share. Total unrestricted cash and cash equivalents at June 30, were $31.6 million, compared to $36.6 million at March 31. The decrease in cash is due primarily to investment in new products and operating losses during the quarter. Amtech Systems is a global provider of production and automation systems and related consumables used in fabricating solar cells, LEDs and semiconductor devices. More Information: amtechsystems.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |